These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6328994

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An interesting case of osteomalacia due to antacid use associated with stainable bone aluminum in a patient with normal renal function.
    Woodson GC.
    Bone; 1998 Jun; 22(6):695-8. PubMed ID: 9626411
    [Abstract] [Full Text] [Related]

  • 3. Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature.
    Chines A, Pacifici R.
    Calcif Tissue Int; 1990 Nov; 47(5):291-5. PubMed ID: 2257522
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E, Mioni G, Maschio G, D'Angelo A, Ossi E.
    Nephron; 1975 Nov; 14(2):163-80. PubMed ID: 1093055
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antacid-induced osteomalacia: a case report with a histomorphometric analysis.
    Kassem M, Eriksen EF, Melsen F, Mosekilde L.
    J Intern Med; 1991 Mar; 229(3):275-9. PubMed ID: 2007845
    [Abstract] [Full Text] [Related]

  • 11. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB, Sherrard DJ, Alfrey AC, Ott S, Brickman AS, Miller NL, Maloney NA, Coburn JW.
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [Abstract] [Full Text] [Related]

  • 12. Antacid-induced osteomalacia and nephrolithiasis.
    Cooke N, Teitelbaum S, Avioli LV.
    Arch Intern Med; 1978 Jun; 138(6):1007-9. PubMed ID: 646554
    [Abstract] [Full Text] [Related]

  • 13. Elevated bone aluminum content in dialysis patients without osteomalacia.
    McCarthy JT, Kurtz SB, McCall JT.
    Mayo Clin Proc; 1985 May; 60(5):315-20. PubMed ID: 3990380
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antacid-induced osteomalacia.
    Boutsen Y, Devogelaer JP, Malghem J, Noel H, Nagant de Deuxchaisnes C.
    Clin Rheumatol; 1996 Jan; 15(1):75-80. PubMed ID: 8929782
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dietary induction of osteitis fibrosa cystica in the rat: roles of parathyroid hormone and calcitonin.
    Clark I, Brashear HR.
    Calcif Tissue Res; 1976 Aug; 21 Suppl():272-7. PubMed ID: 953813
    [No Abstract] [Full Text] [Related]

  • 18. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG.
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia.
    Andress D, Felsenfeld AJ, Voigts A, Llach F.
    Kidney Int; 1983 Sep; 24(3):364-70. PubMed ID: 6645210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.